NewsPR Newswire
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
· Published
Article summary
China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a termination letter agreement with the purchasers in its registered direct offering announced on October 8, 2026 (the "Offering"). Under...
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…